607 related articles for article (PubMed ID: 17620116)
1. Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.
Paschoalin T; Carmona AK; Rodrigues EG; Oliveira V; Monteiro HP; Juliano MA; Juliano L; Travassos LR
Mol Cancer; 2007 Jul; 6():44. PubMed ID: 17620116
[TBL] [Abstract][Full Text] [Related]
2. Characterization of thimet- and neurolysin-like activities in Escherichia coli M 3 A peptidases and description of a specific substrate.
Paschoalin T; Carmona AK; Oliveira V; Juliano L; Travassos LR
Arch Biochem Biophys; 2005 Sep; 441(1):25-34. PubMed ID: 16098472
[TBL] [Abstract][Full Text] [Related]
3. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model.
Kibbey MC; Grant DS; Kleinman HK
J Natl Cancer Inst; 1992 Nov; 84(21):1633-8. PubMed ID: 1279183
[TBL] [Abstract][Full Text] [Related]
4. Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion.
Zhang LJ; Chen L; Lu Y; Wu JM; Xu B; Sun ZG; Zheng SZ; Wang AY
Eur J Pharmacol; 2010 Sep; 643(2-3):195-201. PubMed ID: 20621088
[TBL] [Abstract][Full Text] [Related]
5. Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres.
Franco S; Segura I; Riese HH; Blasco MA
Cancer Res; 2002 Jan; 62(2):552-9. PubMed ID: 11809709
[TBL] [Abstract][Full Text] [Related]
6. Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis.
Kang IC; Kim DS; Jang Y; Chung KH
Biochem Biophys Res Commun; 2000 Aug; 275(1):169-73. PubMed ID: 10944460
[TBL] [Abstract][Full Text] [Related]
7. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
Hamsa TP; Kuttan G
Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
[TBL] [Abstract][Full Text] [Related]
8. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.
Koszałka P; Gołuńska M; Stanisławowski M; Urban A; Stasiłojć G; Majewski M; Wierzbicki P; Składanowski AC; Bigda J
Int J Biochem Cell Biol; 2015 Dec; 69():1-10. PubMed ID: 26545615
[TBL] [Abstract][Full Text] [Related]
9. The role of Tyr605 and Ala607 of thimet oligopeptidase and Tyr606 and Gly608 of neurolysin in substrate hydrolysis and inhibitor binding.
Machado MF; Rioli V; Dalio FM; Castro LM; Juliano MA; Tersariol IL; Ferro ES; Juliano L; Oliveira V
Biochem J; 2007 Jun; 404(2):279-88. PubMed ID: 17313369
[TBL] [Abstract][Full Text] [Related]
10. Barbigerone inhibits tumor angiogenesis, growth and metastasis in melanoma.
Yang JH; Hu J; Wan L; Chen LJ
Asian Pac J Cancer Prev; 2014; 15(1):167-74. PubMed ID: 24528020
[TBL] [Abstract][Full Text] [Related]
11. Peptide R18H from BRN2 Transcription Factor POU Domain Displays Antitumor Activity In Vitro and In Vivo and Induces Apoptosis in B16F10-Nex2 Cells.
da Cunha FFM; Mugnol KCU; de Melo FM; Nascimento MVSQ; de Azevedo RA; Santos RTS; Magalhães JA; Miguel DC; Tada DB; Mortara RA; Travassos LR; Arruda DC
Anticancer Agents Med Chem; 2019; 19(3):389-401. PubMed ID: 30417795
[TBL] [Abstract][Full Text] [Related]
12. Macrophages, IL-10, and nitric oxide increase, induced by hyperglycemic conditions, impact the development of murine melanoma B16F10-Nex2.
Sellani TA; Tomaz SL; Gonçalves JM; Lima A; de Amat Herbozo CC; Silva GN; Gambero M; Longo-Maugéri IM; Simon KA; Monteiro HP; Rodrigues EG
Nitric Oxide; 2024 Jul; 148():1-12. PubMed ID: 38636582
[TBL] [Abstract][Full Text] [Related]
13. Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma.
Dua P; Ingle A; Gude RP
Int J Cancer; 2007 Oct; 121(7):1600-8. PubMed ID: 17582610
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects in vitro and in vivo and mechanisms of protection against melanoma B16F10-Nex2 cells by fastuosain, a cysteine proteinase from Bromelia fastuosa.
Guimarães-Ferreira CA; Rodrigues EG; Mortara RA; Cabral H; Serrano FA; Ribeiro-dos-Santos R; Travassos LR
Neoplasia; 2007 Sep; 9(9):723-33. PubMed ID: 17898868
[TBL] [Abstract][Full Text] [Related]
15. In vivo modulation of angiogenesis by beta 2 glycoprotein I.
Passam FH; Qi JC; Tanaka K; Matthaei KI; Krilis SA
J Autoimmun; 2010 Nov; 35(3):232-40. PubMed ID: 20655705
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.
Kaliski A; Maggiorella L; Cengel KA; Mathe D; Rouffiac V; Opolon P; Lassau N; Bourhis J; Deutsch E
Mol Cancer Ther; 2005 Nov; 4(11):1717-28. PubMed ID: 16275993
[TBL] [Abstract][Full Text] [Related]
17. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
[TBL] [Abstract][Full Text] [Related]
18. Identification of iGb3 and iGb4 in melanoma B16F10-Nex2 cells and the iNKT cell-mediated antitumor effect of dendritic cells primed with iGb3.
Dias BR; Rodrigues EG; Nimrichter L; Nakayasu ES; Almeida IC; Travassos LR
Mol Cancer; 2009 Dec; 8():116. PubMed ID: 19968878
[TBL] [Abstract][Full Text] [Related]
19. β-Caryophyllene potently inhibits solid tumor growth and lymph node metastasis of B16F10 melanoma cells in high-fat diet-induced obese C57BL/6N mice.
Jung JI; Kim EJ; Kwon GT; Jung YJ; Park T; Kim Y; Yu R; Choi MS; Chun HS; Kwon SH; Her S; Lee KW; Park JH
Carcinogenesis; 2015 Sep; 36(9):1028-39. PubMed ID: 26025912
[TBL] [Abstract][Full Text] [Related]
20. Melanoma heterogeneity: differential, invasive, metastatic properties and profiles of cathepsin B, D and L activities in subclones of the B16F10-NEX2 cell line.
Freitas ZF; Rodrigues EG; Oliveira V; Carmona AK; Travassos LR
Melanoma Res; 2004 Oct; 14(5):333-44. PubMed ID: 15457088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
